The Umesh Modi Group has reportedly sought a valuation of up to ₹4,000 crore for the pharmaceutical firm as it looks to offload a minority stake to private equity investors.
Betadine maker Win-Medicare eyes $150-200 million stake sale; taps EY
The Umesh Modi Group has reportedly sought a valuation of up to ₹4,000 crore for the pharmaceutical firm as it looks to offload a minority stake to private equity investors.
